{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:50:04Z","timestamp":1787021404759,"version":"build-2736575974"},"reference-count":64,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.1248\/bpb.b25-00037","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:07:24Z","timestamp":1745431644000},"page":"440-449","source":"Crossref","is-referenced-by-count":2,"title":["Dual Anti-inflammatory Actions of a Novel Retinoid X Receptor Agonist Derived from a Natural Compound in Microglial Cells"],"prefix":"10.1248","volume":"48","author":[{"given":"Koji","family":"Tomita","sequence":"first","affiliation":[{"name":"Laboratory of Natural Resources, School of Pharmacy, Aichi Gakuin University, 1\u2013100 Kusumoto-cho, Chikusa-ku, Nagoya 464\u20138650, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Laboratory of Natural Resources, School of Pharmacy, Aichi Gakuin University, 1\u2013100 Kusumoto-cho, Chikusa-ku, Nagoya 464\u20138650, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Organic and Medicinal Chemistry, Laboratory of Pharmaceutical Synthetic Chemistry, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akichika","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Organic and Medicinal Chemistry, Laboratory of Pharmaceutical Synthetic Chemistry, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[{"name":"Laboratory of Natural Resources, School of Pharmacy, Aichi Gakuin University, 1\u2013100 Kusumoto-cho, Chikusa-ku, Nagoya 464\u20138650, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Jansen IE, Savage JE, Watanabe K, et al<\/i>. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet.<\/i>, 51<\/b>, 404\u2013413 (2019)."},{"key":"2","unstructured":"2) Wightman DP, Jansen IE, Savage JE, et al<\/i>. A genome-wide association study with 1,126,653 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat. Genet.<\/i>, 53<\/b>, 1276\u20131282 (2021)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Efthymiou AG, Goate AM. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol. Neurodegener.<\/i>, 12<\/b>, 43 (2017).","DOI":"10.1186\/s13024-017-0184-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement.<\/i> (N. Y.), 4<\/b>, 575\u2013590 (2018).","DOI":"10.1016\/j.trci.2018.06.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience<\/i>, 39<\/b>, 151\u2013170 (1990).","DOI":"10.1016\/0306-4522(90)90229-W"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Spittau B. Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases. Front. Aging Neurosci<\/i>, 9<\/b>, 194 (2017).","DOI":"10.3389\/fnagi.2017.00194"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bar E, Barak B. Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders. Glia<\/i>, 67<\/b>, 2125\u20132141 (2019).","DOI":"10.1002\/glia.23637"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J. Cell Biol.<\/i>, 217<\/b>, 459\u2013472 (2018).","DOI":"10.1083\/jcb.201709069"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol.<\/i>, 11<\/b>, 775\u2013787 (2011).","DOI":"10.1038\/nri3086"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Venegas C, Heneka MT. Danger-associated molecular patterns in Alzheimer\u2019s disease. J. Leukoc. Biol.<\/i>, 101<\/b>, 87\u201398 (2017).","DOI":"10.1189\/jlb.3MR0416-204R"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell<\/i>, 140<\/b>, 918\u2013934 (2010).","DOI":"10.1016\/j.cell.2010.02.016"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol.<\/i>, 6<\/b>, 193\u2013201 (2010).","DOI":"10.1038\/nrneurol.2010.17"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Moutinho M, Codocedo JF, Puntambekar SS, Landreth GE. Nuclear receptors as therapeutic targets for neurodegenerative diseases: lost in translation. Annu. Rev. Pharmacol. Toxicol.<\/i>, 59<\/b>, 237\u2013261 (2019).","DOI":"10.1146\/annurev-pharmtox-010818-021807"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sharma S, Shen T, Chitranshi N, Gupta V, Basavarajappa D, Sarkar S, Mirzaei M, You Y, Krezel W, Graham SL, Gupta V. Correction to: Retinoid X receptor: cellular and biochemical roles of nuclear receptor with a focus on neuropathological involvement. Mol. Neurobiol.<\/i>, 59<\/b>, 2051 (2022).","DOI":"10.1007\/s12035-022-02767-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Moutinho M, Landreth GE. Therapeutic potential of nuclear receptor agonists in Alzheimer\u2019s disease. J. Lipid Res.<\/i>, 58<\/b>, 1937\u20131949 (2017).","DOI":"10.1194\/jlr.R075556"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gui Y, Duan S, Xiao L, Tang J, Li A. Bexarotent attenuated chronic constriction injury-induced spinal neuroinflammation and neuropathic pain by targeting mitogen-activated protein kinase phosphatase-1. J. Pain.<\/i>, 21<\/b>, 1149\u20131159 (2020).","DOI":"10.1016\/j.jpain.2019.01.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Zuo Y, Huang L, Enkhjargal B, Xu W, Umut O, Travis ZD, Zhang G, Tang J, Liu F, Zhang JH. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via<\/i> PPAR\u03b3<\/i>\/SIRT6\/FoxO3a pathway after subarachnoid hemorrhage in rats. J. Neuroinflammation<\/i>, 16<\/b>, 47 (2019).","DOI":"10.1186\/s12974-019-1432-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) He J, Huang Y, Liu H, Sun X, Wu J, Zhang Z, Liu L, Zhou C, Jiang S, Huang Z, Zhong J, Guo Z, Jiang L, Cheng C. Bexarotene promotes microglia\/macrophages-specific brain-derived neurotrophic factor expression and axon sprouting after traumatic brain injury. Exp. Neurol.<\/i>, 334<\/b>, 113462 (2020).","DOI":"10.1016\/j.expneurol.2020.113462"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yuan C, Dai C, Li Z, Zheng L, Zhao M, Dong S. Bexarotene improve depression-like behaviour in mice by protecting against neuro-inflammation and synaptic damage. Neurochem. Res.<\/i>, 45<\/b>, 1500\u20131509 (2020).","DOI":"10.1007\/s11064-020-03012-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mangelsdorf DJ, Evans EM. The RXR heterodimers and orphan receptors. Cell<\/i>, 83<\/b>, 841\u2013850 (1995).","DOI":"10.1016\/0092-8674(95)90200-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-\u03b3<\/i>. Nature<\/i>, 437<\/b>, 759\u2013763 (2005).","DOI":"10.1038\/nature03988"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Park EJ, Park SY, Joe EH, Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1(SOCS1) and SOCS3 in glia. J. Biol. Chem.<\/i>, 278<\/b>, 14747\u201314752 (2003).","DOI":"10.1074\/jbc.M210819200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Xing B, Xin T, Hunter RL, Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K\/Akt. J. Neuroinflammation.<\/i>, 5<\/b>, 4 (2008).","DOI":"10.1186\/1742-2094-5-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J. Neuroimmunol.<\/i>, 161<\/b>, 113\u2013122 (2005).","DOI":"10.1016\/j.jneuroim.2004.12.015"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Castro LVG, Gon\u00e7alves-de-Albuquerque CF, Silva AR. Polarization of microglia and its therapeutic potential in sepsis. Int. J. Mol. Sci.<\/i>, 23<\/b>, 4925 (2022).","DOI":"10.3390\/ijms23094925"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPAR\u03b3<\/i> controls alternative activation and improves insulin resistance. Nature<\/i>, 447<\/b>, 1116\u20131120 (2007).","DOI":"10.1038\/nature05894"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Croasdell A, Duffney PF, Kim N, Lacy SH, Sime PJ, Phipps RP. PPAR\u03b3<\/i> and the innate immune system mediate the resolution of inflammation. PPAR Res.<\/i>, 2015<\/b>, 549691 (2015).","DOI":"10.1155\/2015\/549691"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhang M, Hu M, Montera MA, Westlund KN. Sustained relief of trigeminal neuropathic pain by a blood-brain barrier penetrable PPAR gamma agonist. Mol. Pain.<\/i>, 15<\/b>, 1744806919884498 (2019).","DOI":"10.1177\/1744806919884498"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wang W, Nakashima K, Hirai T, Inoue M. Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis<\/i> Gagnep. via<\/i> retinoid X receptor\/liver X receptor heterodimers. J. Nat. Med.<\/i>, 73<\/b>, 419\u2013430 (2019).","DOI":"10.1007\/s11418-018-01277-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Li Y, Xing Q, Wei Y, Zhao L, Zhang P, Han X, Wang J. Activation of RXR by bexarotene inhibits inflammatory conditions in huma rheumatoid arthritis fibroblast-like synoviocytes. Int. J. Mol. Med.<\/i>, 44<\/b>, 1963\u20131970 (2019).","DOI":"10.3892\/ijmm.2019.4336"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-\u03b1<\/i> and the retinoid X receptor inhibit inflammatory responses of microglia. J. Neurosci. Res.<\/i>, 81<\/b>, 403\u2013411 (2005).","DOI":"10.1002\/jnr.20518"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Xu J, Drew PD. 9-Cis<\/i>-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol.<\/i>, 171<\/b>, 135\u2013144 (2006).","DOI":"10.1016\/j.jneuroim.2005.10.004"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-Cis<\/i> retinoic acid is a high affinity ligand for the retinoid X receptor. Cell<\/i>, 68<\/b>, 397\u2013406 (1992).","DOI":"10.1016\/0092-8674(92)90479-V"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF. 9-Cis<\/i> retinoic acid stereoisomer binds and activates the nuclear receptor RXR \u03b1<\/i>. Nature<\/i>, 355<\/b>, 359\u2013361 (1992).","DOI":"10.1038\/355359a0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tian Y, Liu B, Li Y, Zhang Y, Shao J, Wu P, Xu C, Chen G, Shi H. Activation of RAR\u03b1<\/i> receptor attenuates neuroinflammation after SAH via<\/i> promoting M1-to-M2 phenotypic polarization of microglia and regulating Mafb\/Msr1\/PI3K-Akt\/NF-\u03baB pathway. Front. Immunol.<\/i>, 13<\/b>, 839796 (2022).","DOI":"10.3389\/fimmu.2022.839796"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Mariani MM, Malm T, Lamb R, Jay TR, Neilson L, Casali B, Medarametla L, Landreth GE. Neuronally-directed effects of RXR activation in a mouse model of Alzheimer\u2019s disease. Sci. Rep.<\/i>, 7<\/b>, 42270 (2017).","DOI":"10.1038\/srep42270"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Santos-Gil DF, Arboled\u00e1 G, Sandoval-Hern\u00e1ndez AG. Retinoid X receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer\u2019s disease. Neurosci. Lett.<\/i>, 750<\/b>, 135764 (2021).","DOI":"10.1016\/j.neulet.2021.135764"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Mu\u00f1oz-Cabrera JM, Sandoval-Hern\u00e1ndez AG, Ni\u00f1o A, B\u00e1ez T, Bustos-Rangel A, Cardona-G\u00f3mez GP, M\u00fanera A, Arboleda G. Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old triple transgenic mice model of Alzheimer \u0301s disease. PLOS ONE<\/i>, 14<\/b>, e0223578 (2019).","DOI":"10.1371\/journal.pone.0223578"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Mounier A, Georgiev D, Nam KN, Fitz NF, Castranio EL, Wolfe CM, Cronican AA, Schug J, Lefterov I, Koldamova R. Bexarotene-activated retinoid X receptors regulate neuronal differentiation and dendritic complexity. J. Neurosci.<\/i>, 35<\/b>, 11862\u201311876 (2015).","DOI":"10.1523\/JNEUROSCI.1001-15.2015"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, Crowley C, Yocum RC. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J. Clin. Oncol.<\/i>, 19<\/b>, 2456\u20132471 (2001).","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"41","unstructured":"41) Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA, Yocum RC. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch. Dermatol.<\/i>, 137<\/b>, 581\u2013593 (2001)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, Duvic M. Central hypothyroidism associated with retinoid X receptor-selective ligands. N. Engl. J. Med.<\/i>, 340<\/b>, 1075\u20131079 (1999).","DOI":"10.1056\/NEJM199904083401404"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) van der Wees J, Schilthuis JG, Koster CH, Diesveld-Schipper H, Folkers GE, van der Saag PT, Dawson MI, Shudo K, van der Burg B, Durston AJ. Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the develping hindbrain. Development<\/i>, 125<\/b>, 545\u2013556 (1998).","DOI":"10.1242\/dev.125.3.545"},{"key":"44","unstructured":"44) Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RPJr. Initial clinical trial of the retinoid receptor pan agonist 9-cis<\/i> retinoic acid. Clin. Cancer Res.<\/i>, 2<\/b>, 471\u2013475 (1996)."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Kotani H, Tanabe H, Mizukami H, Makishima M, Inoue M. Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor. J. Nat. Prod.<\/i>, 73<\/b>, 1332\u20131336 (2010).","DOI":"10.1021\/np100120c"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Inoue M, Tanabe H, Nakashima K, Ishida Y, Kotani H. Rexinoids isolated from Sophora tonkinensis<\/i> with a gene expression profile distinct from the synthetic rexinoid bexarotene. J. Nat. Prod.<\/i>, 77<\/b>, 1670\u20131677 (2014).","DOI":"10.1021\/np5002016"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Nakashima K, Murakami T, Tanabe H, Inoue M. Identification of a naturally occurring retinoid X receptor agonist from Brazilian green propolis. Biochim. Biophys. Acta, Gen. Subj.<\/i>, 1840<\/b>, 3034\u20133041 (2014).","DOI":"10.1016\/j.bbagen.2014.06.011"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Kotani H, Tanabe H, Mizukami H, Amagaya S, Inoue M. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers. Biol. Pharm. Bull.<\/i>, 35<\/b>, 1\u20139 (2012).","DOI":"10.1248\/bpb.35.1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Nakashima K, Yamaguchi E, Noritake C, Mitsugi Y, Goto M, Hirai T, Abe N, Sakai E, Oyama M, Itoh A, Inoue M. Discovery and SAR of natural-product-inspired RXR agonists with heterodimer selectivity to PPAR\u03b4-RXR. ACS Chem. Biol.<\/i>, 15<\/b>, 1526\u20131534 (2020).","DOI":"10.1021\/acschembio.0c00146"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Nakashima K, Okamura M, Matsumoto I, Kameda N, Tsuboi T, Yamaguchi E, Itoh A, Inoue M. Regulation of adipogenesis through retinoid X receptor and\/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells. J. Nat. Med.<\/i>, 77<\/b>, 315\u2013326 (2023).","DOI":"10.1007\/s11418-022-01674-7"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Ohsawa K, Imai Y, Nakajima K, Kohsaka S. Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. Glia<\/i>, 21<\/b>, 285\u2013298 (1997).","DOI":"10.1002\/(SICI)1098-1136(199711)21:3<285::AID-GLIA4>3.3.CO;2-1"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN, Bertics PJ. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK\/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J. Biol. Chem.<\/i>, 277<\/b>, 9077\u20139087 (2002).","DOI":"10.1074\/jbc.M104385200"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4-dependent production of PPAR-\u03b3<\/i> ligands in macrophages by 12\/15-lipoxygenase. Nature<\/i>, 400<\/b>, 378\u2013382 (1999).","DOI":"10.1038\/22572"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Lee B, Wu CY, Lin YW, Park SW, Wei LN. Synergistic activation of Arg1 gene by retinoic acid and IL-4 involves chromatin remodeling for transcription initiation and elongation coupling. Nucleic Acids Res.<\/i>, 44<\/b>, 7568\u20137579 (2016).","DOI":"10.1093\/nar\/gkw392"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Lee WJ, Ham SA, Yoo H, Hwang JS, Yoo T, Paek KS, Lim DS, Han SG, Lee CH, Hong K, Seo HG. Activation of PPAR\u03b4 attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells. J. Cell. Biochem.<\/i>, 119<\/b>, 5609\u20135619 (2018).","DOI":"10.1002\/jcb.26732"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J. Neuroimmunol.<\/i>, 183<\/b>, 50\u201359 (2007).","DOI":"10.1016\/j.jneuroim.2006.11.007"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, Glass CK. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPAR\u03b3<\/i>. Mol. Cell<\/i>, 25<\/b>, 57\u201370 (2007).","DOI":"10.1016\/j.molcel.2006.11.022"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br. J. Pharmacol.<\/i>, 173<\/b>, 649\u2013665 (2016).","DOI":"10.1111\/bph.13139"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Feng X, Ji Y, Zhang C, Jin T, Li J, Guo J. CCL6 promotes M2 polarization and inhibits macrophage autophagy by activating PI3-kinase\/Akt signalling pathway during skin wound healing. Exp. Dermatol.<\/i>, 32<\/b>, 403\u2013412 (2023).","DOI":"10.1111\/exd.14718"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Franco R, Fern\u00e1ndez-Su\u00e1rez D. Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol.<\/i>, 131<\/b>, 65\u201386 (2015).","DOI":"10.1016\/j.pneurobio.2015.05.003"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther.<\/i>, 8<\/b>, 207 (2023).","DOI":"10.1038\/s41392-023-01452-1"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Szanto A, Balint BL, Nagy ZS, Barta E, Dezso B, Pap A, Szeles L, Poliska S, Oros M, Evans RM, Barak Y, Schwabe J, Nagy L. STAT6 transcription factor is a facilitator of the nuclear receptor PPAR\u03b3<\/i>-regulated gene expression in macrophages and dendritic cells. Immunity<\/i>, 33<\/b>, 699\u2013712 (2010).","DOI":"10.1016\/j.immuni.2010.11.009"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Daniel B, Nagy G, Czimmerer Z, Horvath A, Hammers DW, Cuaranta-Monroy I, Poliska S, Tzerpos P, Kolostyak Z, Hays TT, Patsalos A, Houtman R, Sauer S, Francois-Deleuze J, Rastinejad F, Balint BL, Sweeney HL, Nagy L. The nuclear receptor PPAR\u03b3<\/i> controls progressive macrophage polarization as a ligand-insensitive epigenomic ratchet of transcriptional memory. Immunity<\/i>, 49<\/b>, 615\u2013626.e6 (2018).","DOI":"10.1016\/j.immuni.2018.09.005"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Munder M. Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol.<\/i>, 158<\/b>, 638\u2013651 (2009).","DOI":"10.1111\/j.1476-5381.2009.00291.x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:24:15Z","timestamp":1745623455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00037","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"b25-00037"}}